Table 2. Follow-up information at 6 months.
| All (n = 49) | Groups | P-value | ||
|---|---|---|---|---|
| Telemonitoring | Hospital monitoring | |||
| Number of transmissions from hospital N (%) | ||||
| 0 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.26 |
| 1 | 41 (83.7) | 21 (84.0) | 20 (83.3) | |
| 2 | 6 (12.2) | 2 (8.0) | 4 (16.7) | |
| 3 | 2 (4.1) | 2 (8.0) | 0 (0.0) | |
| Number of transmissions from patient’s home N (%) | ||||
| 0 | 29 (59.2) | 5 (20.0) | 24 (100) | <0.001 |
| 3–5 | 15 (30.6) | 15 (60.0) | 0 (0.0) | |
| 6–8 | 5 (10.2) | 5 (20.0) | 0 (0.0) | |
| Extra transmissions from patient’s home N (%) | ||||
| 0 | 45 (91.8) | 21 (84.0) | 24 (100) | 0.12 |
| 1 | 1 (2.0) | 1 (4.0) | 0 (0.0) | |
| 3 | 3 (6.2) | 3 (12.0) | 0 (0.0) | |
| Cardiovascular events N (%) | ||||
| None | 46 (93.9) | 23 (92.0) | 23 (95.8) | 0.40 |
| PCI | 1 (2.0) | 1 (4.0) | 0 (0.0) | |
| Angina | 1 (2.0) | 0 (0.0) | 1 (4.2) | |
| Lead dislodgement x 2 | 1 (2.0) | 1 (2.0) | 0 (0.0) | |
| Calls/letters sent to the patients N (%) | ||||
| 0 | 27 (55.1) | 4 (16.0) | 23 (95.8) | <0.001 |
| 1 | 21 (42.9) | 20 (80.0) | 1 (4.2) | |
| 3 | 1 (2.0) | 1 (4.0) | 0 (0.0) | |
| Changes of medication N (%) | ||||
| 0 | 33 (67.3) | 17 (68.0) | 16 (66.7) | 0.11 |
| 1 | 7 (14.3) | 5 (20.0) | 2 (8.3) | |
| 2 | 3 (6.1) | 1 (4.0) | 2 (8.3) | |
| 3 | 4 (8.2) | 0 (0.0) | 4 (16.7) | |
| 4 | 2 (4.1) | 2 (8.0) | 0 (0.0) | |
| Changes of pacemaker’s reprogramming N (%) | ||||
| 0 | 34 (69.4) | 16 (64.0) | 18 (75.0) | 0.34 |
| 1 | 13 (26.5) | 7 (28.0) | 6 (25.0) | |
| 2 | 2 (4.1) | 2 (8.0) | 0 (0.0) | |
| Number of hospitalisations (related or not to pacemaker’s implant) N (%) | ||||
| 0 | 30 (61.2) | 14 (56.0) | 16 (66.7) | 0.55 |
| 1 | 14 (28.6) | 7 (28.0) | 7 (29.2) | |
| 2 | 4 (8.2) | 3 (12.0) | 1 (4.2) | |
| 5 | 1 (2.0) | 1 (2.0) | 0 (0.0) | |
| Number of hospitalisation days (related or not to pacemaker’s implant) N (%) | ||||
| 0 | 30 (61.2) | 14 (56.0) | 16 (66.7) | 0.54 |
| 1–5 | 12 (24.5) | 6 (24.0) | 6 (25.1) | |
| 6–10 | 4 (8.1) | 2 (8.0) | 2 (8.4) | |
| +10 | 3 (6.0) | 3 (12.0) | 0 (0.0) | |
| Reasons for hospitalisation N (%) | ||||
| None | 30 (61.2) | 14 (56.0) | 16 (66.7) | 0.37 |
| Others | 6 (12.3) | 3 (12.0) | 3 (12.5) | |
| Cancer | 1 (2.0) | 1 (4.0) | 0 (0.0) | |
| Coronary problems | 9 (18.4) | 4 (16.0) | 5 (20.8) | |
| Pacemaker dysfunction | 3 (6.1) | 3 (12.0) | 0 (0.0) | |
n = 50 (Telemonitoring group: 25; Hospital monitoring group: 24). Values are expressed as means or proportions. SD: Standard deviation; 95 CI: 95% confidence interval of means; PCI: Percutaneous coronary intervention. Note: this table has been previously published in a previous article [27].